Regeneron Says CHMP Recommends Conditional Marketing Authorization For Odronextamab In EU

RTTNews | 425 dni temu
Stocktwits
Regeneron Says CHMP Recommends Conditional Marketing Authorization For Odronextamab In EU

(RTTNews) - Regeneron Pharmaceuticals, Inc. (REGN) announced Friday that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending conditional marketing authorization of odronextamab to treat adults with relapsed/refractory (R/R) follicular lymphoma (FL) or R/R diffuse large B-cell lymphoma (DLBCL), after two or more lines of systemic therapy.

The European Commission is expected to announce a final decision in the coming months. FL and DLBCL are the two most common subtypes of B-cell non-Hodgkin lymphoma (B-NHL).

The positive CHMP opinion is supported by results from the Phase 1 ELM-1 and pivotal Phase 2 ELM-2 trials, which demonstrated robust, durable response rates and an acceptable safety profile of odronextamab in adults with R/R FL or R/R DLBCL. The EMA previously granted odronextamab Orphan Designation for both FL and DLBCL. Odronextamab is currently under clinical development and has not been approved by any regulatory authority.

Regeneron continues to evaluate the use of odronextamab as a monotherapy and in combination across earlier lines of therapy in challenging-to-treat lymphomas.

Tagi: REGN
Stocktwits
read more
Regeneron Pharma Q2 Results Top Estimates - Update

Regeneron Pharma Q2 Results Top Estimates - Update

Biotechnology company Regeneron Pharmaceuticals, Inc. (REGN) reported on Thursday that net income for the second quarter increased to $1.43 billion or $12.41 per share from $968 million or $8.50 per share in the prior-year quarter.
RTTNews | 391 dni temu
Regeneron Pharma Q4 Results Top Estimates - Update

Regeneron Pharma Q4 Results Top Estimates - Update

Regeneron Pharmaceuticals, Inc. (REGN) reported on Friday that net income for the fourth quarter declined 3 percent to $1.16 billion or $10.19 per share from $1.20 billion or $10.50 per share in the prior-year quarter.
RTTNews | 572 dni temu
Regeneron Completes Acquiring Sanofi's Stake In Libtayo

Regeneron Completes Acquiring Sanofi's Stake In Libtayo

Regeneron Pharmaceuticals, Inc. (REGN) announced Friday that it has completed the acquisition of French drug major Sanofi's (SNYNF, SNY) stake in Libtayo (cemiplimab), providing Regeneron with exclusive worldwide development, commercialization, and manufacturing rights to the medicine originally discovered in Regeneron's laboratories. The intent to purchase Libtayo was announced on June 2, 2022.
RTTNews | 1153 dni temu
China Stock Market May Stop The Bleeding On Thursday

China Stock Market May Stop The Bleeding On Thursday

The China stock market has finished lower in two straight sessions, retreating more than 80 points or 2.1 percent along the way. The Shanghai Composite Index now sits just above the 3,800-point plateau although it's due for support on Thursday.
RTTNews | 7 minut temu
Taiwan Stock Market May Extend Winning Streak

Taiwan Stock Market May Extend Winning Streak

The Taiwan stock market has tracked higher in three straight sessions, gathering more than 750 points or 3.1 percent along the way. The Taiwan Stock Exchange now rests just beneath the 24,520-point plateau and it may add to its winnings again on Thursday.
RTTNews | 37 minut temu
Singapore Stock Market May Extend Wednesday's Gains

Singapore Stock Market May Extend Wednesday's Gains

The Singapore stock market bounced higher again on Wednesday, one day after snapping the five-day winning streak in which it had climbed almost 70 points or 1.6 percent. The Straits Times Index now sits just above the 4,245-point plateau and it may pick up steam on Thursday.
RTTNews | 1g 7 minut temu
Malaysia Bourse May Add To Its Winnings On Thursday

Malaysia Bourse May Add To Its Winnings On Thursday

The Malaysia stock market rebounded on Wednesday, one day after ending the three-day winning streak in which it had collected almost 15 points or 0.9 percent. The Kuala Lumpur Composite Index now sits just above the 1,585-point plateau and it's expected to open in the green again on Thursday.
RTTNews | 1g 37 minut temu
Narzędzia
Kalendarz ekonomiczny
Godziny handlu
Stopy procentowe
Kalendarz świąt
Rynek Forex
Zmienność na rynku Forex
Korelacja na rynku Forex
Wiadomości Forex
Analiza rynku Forex
Dane COT
Płynność
Kalkulatory Forex
Mapa termiczna Forex
Mapa cieplna wskaźników
Społeczność
Społeczność
System
Najpopularniejsze systemy
Strategie
Konkursy
Wykresy Forex
Nastroje na rynku Forex
Wskaźnik prognozy
Recenzje
Brokerzy
Firmy proprietary trading
Usługi VPS
Dostawcy sygnałów
Usługi programistyczne EA
Programy partnerskie
Usługi brokerów PAMM
Usługi programu rabatowego
Platformy transakcyjne
Doradca
Giełdy kryptowalut
Kursy handlowe
Brokerzy
Spready na rynku Forex
Notowania brokera Forex
Swapy brokerów Forex
Wolumen brokera Forex
Akcje brokerów Forex
Informacja Prasowa
Platforma
Widgety
Funkcje
API
RSS
Stock Portfolio
Affiliate Software
Zaawansowane wykresy
Wsparcie
Najczęstsze pytania
Pomoc
Kontakt z nami
Zgłoś błąd!
O nas
Blog
© 2025 Myfxbook Ltd. Wszelkie Prawa Zastrzeżone.
Ostrzeżenie o wysokim ryzyku: handel walutami obcymi wiąże się z wysokim poziomem ryzyka, który może nie być odpowiedni dla wszystkich inwestorów. Dźwignia stwarza dodatkowe ryzyko i ryzyko straty. Zanim zdecydujesz się na handel walutami, dokładnie przemyśl swoje cele inwestycyjne, poziom doświadczenia i tolerancję ryzyka. Możesz stracić część lub całość początkowej inwestycji. Nie inwestuj pieniędzy, których nie możesz stracić. Zbadaj ryzyko związane z handlem walutami i zasięgnij porady niezależnego doradcy finansowego lub podatkowego, jeśli masz jakiekolwiek pytania. Wszelkie dane i informacje są dostarczane "tak, jak są" wyłącznie w celach informacyjnych i nie są przeznaczone do celów handlowych ani konsultacji. Wcześniejsze wyniki nie są wskaźnikiem przyszłych wyników.